The effects of perioperative enteral immunonutrition in patients with gastric cancer

Yong YIN,Jun XU,Qi-cheng LU,Qin WANG,Zhong LI,Hai-tao WANG,Rong-chao WANG
DOI: https://doi.org/10.3969/j.issn.1007-810X.2008.04.008
2008-01-01
Abstract:Objective:To evaluate the effects of perioperative enteral immunonutrition on immune function and clinical outcome in patients with gastric cancer.Methods: Forty-six patients were randomly allocated into two groups.The first group(n=23) received an enteral immuneenhancing diet 7 d before and 7 d after surgery and the second group(n=23) received the same diet but only 7 d after surgery.The total lymphocyte count(TLC),immunoglobin(IgG,IgM,IgA),T lymphocyte subsets and human leukocyte antigen-DR were determined as host immunity 1 d preoperatively,and 1,9 d postoperatively.The differences between these two groups in postoperative infectious complications and postoperative hospital stay were observed.Results:TLC,IgG,CD4,CD4/CD8 ratio and HLA-DR expression on postoperative day 9 were significantly higher in the perioperative group(P<0.05 versus the postoperative group).The rate of postoperative infectious complications in the perioperative group was lower than in the postoperative group(4.3% vs 17.4%),but there was no significant difference(P>0.05).Perioperative group also showed shorter average length of stay after surgery than postoperative group [(10.8±1.0)d versus(11.8±1.2) d,P<0.05].Conclusion:Compared with the postoperative group,the perioperative administration of enteral immunonutrition can ameliorate the host immune function and improve clinical outcome in gastric cancer patients.
What problem does this paper attempt to address?